Skip to main content
. 2022 Feb;43(2):213–217. doi: 10.15537/smj.2022.43.2.20210736

Table 3.

- Relationship between anticoagulant type and the effectiveness of prothrombin complex concentrate and the dose.

Types of anticoagulants Effective n (%) (M±SD) Ineffective n (%) (M±SD) Total (n,%) P-value
VKA PCC dose 14 (88)
2196±573.3
2 (12)
1000±707.1
16 (100) 0.02
Dabigatran PCC dose 1 (50)
2000
1 (50)
2500
2 (100)  
Rivaroxaban PCC dose 4 (100)
2156±986.2
0 4 (100)  
PCC: prothrombin complex concentrate